Pitcairn’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-30,950
Closed -$157K 356
2025
Q3
$157K Sell
30,950
-24,470
-44% -$108K 0.01% 614
2025
Q2
$239K Sell
55,420
-1,942
-3% -$9.6K 0.02% 630
2025
Q1
$346K Buy
57,362
+5,943
+12% +$30K 0.02% 539
2024
Q4
$203K Buy
51,419
+1,407
+3% +$6.3K 0.01% 680
2024
Q3
$293K Sell
50,012
-10,355
-17% -$51.1K 0.02% 599
2024
Q2
$260K Buy
60,367
+2,923
+5% +$14K 0.02% 624
2024
Q1
$270K Buy
57,444
+22,644
+65% +$86.7K 0.02% 607
2023
Q4
$171K Buy
+34,800
New +$170K 0.01% 656
2023
Q3
Sell
-15,762
Closed -$146K 674
2023
Q2
$146K Buy
15,762
+5,371
+52% +$45.4K 0.01% 638
2023
Q1
$85.4K Sell
10,391
-7,993
-43% -$88.3K 0.01% 593
2022
Q4
$205K Buy
+18,384
New +$214K 0.02% 562

Other funds holding MPT

Pitcairn's MPT Position: Q4 2025 in Review

Pitcairn sold out of Medical Properties Trust (MPT) in Q4 2025, closing a stake of 30,950 shares — an estimated $157K sold.

Pitcairn first reported a position in MPT in Q4 2022 and held it in 11 quarters. The position peaked at $346K in Q1 2025. 485 funds tracked by Wall St. Rank hold MPT as of Q4 2025.

  • Pitcairn reported no remaining Medical Properties Trust position as of Q4 2025 after selling out during the quarter.
  • Pitcairn sold 30,950 Medical Properties Trust shares in Q4 2025, an estimated $157K.
  • Pitcairn first reported a position in Medical Properties Trust in Q4 2022 and held it in 11 quarters.
  • Pitcairn's Medical Properties Trust position peaked at $346K in Q1 2025.
  • 485 funds tracked by Wall St. Rank held Medical Properties Trust as of Q4 2025.

Based on Pitcairn's 13F filing for Q4 2025.